Quick10K

⚲

Foundation Medicine

Filings

10-Q	2018-06-30	Filed 2018-08-09
10-Q	2018-03-31	Filed 2018-05-02
10-K	2017-12-31	Filed 2018-03-07
10-Q	2017-09-30	Filed 2017-11-01
10-Q	2017-06-30	Filed 2017-08-01
10-Q	2017-03-31	Filed 2017-05-09
10-K	2016-12-31	Filed 2017-03-03
10-Q	2016-09-30	Filed 2016-11-02
10-Q	2016-06-30	Filed 2016-08-03
10-Q	2016-03-31	Filed 2016-05-03
10-K	2015-12-31	Filed 2016-03-01
10-Q	2015-09-30	Filed 2015-11-03
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-13
10-Q	2014-09-30	Filed 2014-11-13
10-Q	2014-06-30	Filed 2014-08-13
10-Q	2014-03-31	Filed 2014-05-13
10-K	2013-12-31	Filed 2014-03-07
10-Q	2013-09-30	Filed 2013-11-12

Reports

8-K	2018-07-31
8-K	2018-06-21
8-K	2018-06-18
8-K	2018-06-06
8-K	2018-05-02
8-K	2018-03-16
8-K	2018-03-07
8-K	2018-02-28
8-K	2018-01-08

Foundation Medicine Financials

FMI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Cash	138	124	110	97	87	72	62	264	250	118	86	62	78	64	49	37	77	71	63	56
Accounts Receivable	4	6	8	6	6	10	11	10	10	7	8	10	7	8	6	14	13	20	32	41
Inventory	1	2	3	3	4	5	4	6	9	8	7	10	12	10	10	9	10	13	16	26
PP&E	27	31	33	35	36	38	45	53	62	69	72	76	82	85	86	89	91	97	102	117
Assets	166	157	147	131	122	112	108	323	315	298	281	262	242	214	169	146	151	169	177	193
Accounts Payable	3	7	5	5	6	7	9	9	12	10	9	11	12	12	10	15	16	22	26	29
Long-Term Debt	0																	60
Liabilities	23	26	26	23	25	26	33	33	42	40	37	42	48	49	42	57	87	137	158	202
Stockholders' Equity	143	132	120	108	97	86	75	290	273	258	244	220	194	165	126	90	63	32	19	-9


Income Statement ($MM)	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Revenue	8	10	11	18	16	19	19	22	25	26	30	28	29	29	26	35	43	49	53	57
Cost of Revenue	3	4	5	9	8	8	9	9	9	10	10	11	15	17	17
Gross Profit	5	5	6	9	9	11	10	14	16	16	20	17	15	12	9
R&D	7	7	7	9	7	8	9	10	12	13	13	18	17	18	23	23	22	23	24	25
SG&A	9	12	11	13	15	17	19	36	23	21	23	27	28	29	32	35	34	37	38	37
Tax
Net Income	-12	-13	-12	-13	-13	-13	-17	-33	-21	-19	-17	-29	-31	-36	-46	-44	-33	-38	-37	-33


Cash Flow ($MM)	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Cash Operating		-10	-13	-10		-10	-11	-37	-4	-11	-10	-19	-21	-18	-42	-25	-22	-32	-39
Cash Investing		-3	-0	-3		-17	-3	-7	-10	-121	-22	-5	36	4	26	12	31	-6	-6
Cash Financing		-1	-0	-0		0	4	246	0	0	0	0	0	-0	2	1	32	32	33